Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT2 | O75908 | 1/20 | 1.00 |
| ▸ | SOAT1 | P35610 | 1/20 | 1.00 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.77 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.77 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.77 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.77 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.77 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.77 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.77 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.77 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.77 |
| ▸ | PSMA5 | P28066 | 2/20 | 0.77 |
| ▸ | PSMB4 | P28070 | 2/20 | 0.77 |
| ▸ | PSMB6 | P28072 | 2/20 | 0.77 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.77 |
| ▸ | PSMB10 | P40306 | 2/20 | 0.77 |
| ▸ | PSMB3 | P49720 | 2/20 | 0.77 |
| ▸ | PSMB2 | P49721 | 2/20 | 0.77 |
| ▸ | PSMA6 | P60900 | 2/20 | 0.77 |
| ▸ | PSMA8 | Q8TAA3 | 2/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29379899 | 1.00 | SOAT2 (1.00) | SOAT2SOAT1PSMB11PSMA7PSMB1 | |
| Oleic Acid Anilide SCHEMBL4143904 | 1.00 | SOAT2 (1.00) | SOAT2SOAT1PSMB11PSMA7PSMB1 | |
| SCHEMBL18240159 | 0.97 | SOAT2 (0.94) | SOAT2SOAT1PSMB11PSMA7PSMB1 | |
| SCHEMBL18240151 | 0.93 | SOAT2 (0.86) | SOAT2SOAT1PSMB11PSMA7PSMB1 | |
| SCHEMBL18240149 | 0.93 | SOAT2 (0.86) | SOAT2SOAT1PSMB11PSMA7PSMB1 | |
| SCHEMBL8743011 | 0.91 | SOAT2 (0.82) | SOAT2SOAT1CYP3A4ALDH1A1HDAC8 | |
| SCHEMBL8742971 | 0.91 | SOAT2 (0.82) | SOAT2SOAT1CYP3A4ALDH1A1HDAC8 | |
| SCHEMBL8743258 | 0.91 | SOAT2 (0.82) | SOAT2SOAT1CYP3A4ALDH1A1HDAC8 | |
| SCHEMBL282938 | 0.91 | SOAT2 (0.82) | SOAT2SOAT1CYP3A4ALDH1A1HDAC8 | |
| SCHEMBL8743085 | 0.91 | SOAT2 (0.82) | SOAT2SOAT1CYP3A4ALDH1A1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | THE PILOT INK CO., LTD. (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260022092-A1 | PROCESS FOR SOLVENT FREE CONTINUOUS SYNTHESIS OF AMIDES AND PEPTIDES | COUNCIL SCIENT IND RES (IN) | 2026-01-22 | — | — | US | disclosed |
| US-12460099-B2 | Reversibly thermochromic composition, reversibly thermochromic microcapsule pigment encapsulating reversibly thermochromic composition, and writing instrument using reversibly thermochromic microcapsule pigment | THE PILOT INK CO., LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| EP-4555002-A1 | PROCESS FOR SOLVENT FREE CONTINUOUS SYNTHESIS OF AMIDES AND PEPTIDES | Council of Scientific & Industrial Research (IN) | 2025-05-21 | — | — | EP | disclosed |
| EP-3608386-B1 | REVERSIBLY THERMOCHROMIC COMPOSITION, AND REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT HAVING SAME ENCLOSED THEREIN | PILOT INK CO LTD (JP) | 2025-02-19 | — | — | EP | disclosed |
| US-12123107-B2 | Reversibly thermochromic composite fiber | KABUSHIKI KAISHA PILOT CORPORATION (JP) | 2024-10-22 | — | — | US | disclosed |
| CN-113646052-B | Reversible thermochromic composition, reversible thermochromic microcapsule pigment, and writing instrument | 百乐墨水株式会社 | 2024-05-17 | — | — | CN | disclosed |
| WO-2024013769-A1 | PROCESS FOR SOLVENT FREE CONTINUOUS SYNTHESIS OF AMIDES AND PEPTIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024013769-A1 | PROCESS FOR SOLVENT FREE CONTINUOUS SYNTHESIS OF AMIDES AND PEPTIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2024-01-18 | — | — | WO | disclosed |
| US-20230018132-A1 | REVERSIBLY THERMOCHROMIC AQUEOUS INKJET PRINTER INK COMPOSITION, INKJET PRINTER AND INK CARTRIDGE USING THE SAME | RISO TECHNOLOGIES CORPORATION (JP) | 2023-01-19 | — | — | US | disclosed |
| WO-2016185025-A1 | A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE | DUBLIN CITY UNIVERSITY (IE) | 2016-11-24 | — | — | WO | disclosed |
| EP-3095444-A1 | A METHOD OF TREATING PERIPHERAL INFLAMMATORY DISEASE | Dublin City University (IE) | 2016-11-23 | — | — | EP | disclosed |
| EP-3095444-A1 | A METHOD OF TREATING PERIPHERAL INFLAMMATORY DISEASE | Dublin City University (IE) | 2016-11-23 | — | — | EP | disclosed |
| US-20090131657-A1 | PROCESS FOR ALKENYLATING CARBOXAMIDES | BASF SE (DE) | 2009-05-21 | — | — | US | disclosed |
| CN-100343442-C | Tackifier for printing paste and composition for printing paste containing the same | ASAHI KAGAKU KOGYO CO LTD (JP) | 2007-10-17 | — | — | CN | disclosed |
| WO-2005037225-A2 | METHODS FOR TREATING DISORDERS OF NEURONAL DEFICIENCY WITH BONE MARROW-DERIVED CELLS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2005-04-28 | — | — | WO | disclosed |
| US-20040115175-A1 | Methods for treating disorders of neuronal deficiency with bone marrow-derived cells | THE BOARD OF TRUSTEES OF THE LELAND | 2004-06-17 | — | — | US | disclosed |
| CN-1412380-A | Tackifier for printing paste and composition for printing paste containing the same | ASAHI KAGAKU KOGYO CO LTD (JP) | 2003-04-23 | — | — | CN | disclosed |
| US-20020168350-A1 | Methods for treating disorders of neuronal deficiency with bone marrow-derived cells | BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, THE | 2002-11-14 | — | — | US | disclosed |
| WO-2002037968-A1 | METHODS FOR TREATING DISORDERS OF NEURONAL DEFICIENCY WITH BONE MARROW-DERIVED CELLS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2002-05-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | TYR, SCO2, HBB | SOAT2 2022/4885SOAT1 2226/4885PSMB11 1983/4885 |
| US-20260022092-A1 | PROCESS FOR SOLVENT FREE CONTINUOUS SYNTHESIS OF AMIDES AND PEPTIDES | TNF, VIP, APP | SOAT2 1779/4885SOAT1 2423/4885PSMB11 650/4885 |
| US-20090131657-A1 | PROCESS FOR ALKENYLATING CARBOXAMIDES | PRMT5, CYC1, CBR3 | SOAT2 3434/4885SOAT1 3570/4885PSMB11 2601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.